ES2893456T3 - Uso de un compuesto de carbamato para tratar preventivamente los dolores de cabeza - Google Patents

Uso de un compuesto de carbamato para tratar preventivamente los dolores de cabeza Download PDF

Info

Publication number
ES2893456T3
ES2893456T3 ES17799673T ES17799673T ES2893456T3 ES 2893456 T3 ES2893456 T3 ES 2893456T3 ES 17799673 T ES17799673 T ES 17799673T ES 17799673 T ES17799673 T ES 17799673T ES 2893456 T3 ES2893456 T3 ES 2893456T3
Authority
ES
Spain
Prior art keywords
compound
pharmaceutical composition
migraine
headaches
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES17799673T
Other languages
English (en)
Spanish (es)
Inventor
Hye Won Shin
Yoon Kyung Park
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SK Biopharmaceuticals Co Ltd
Original Assignee
SK Biopharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SK Biopharmaceuticals Co Ltd filed Critical SK Biopharmaceuticals Co Ltd
Application granted granted Critical
Publication of ES2893456T3 publication Critical patent/ES2893456T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES17799673T 2016-05-19 2017-05-18 Uso de un compuesto de carbamato para tratar preventivamente los dolores de cabeza Active ES2893456T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20160061374 2016-05-19
PCT/KR2017/005171 WO2017200316A1 (ko) 2016-05-19 2017-05-18 두통의 예방학적 치료를 위한 카바메이트 화합물의 용도

Publications (1)

Publication Number Publication Date
ES2893456T3 true ES2893456T3 (es) 2022-02-09

Family

ID=60325338

Family Applications (1)

Application Number Title Priority Date Filing Date
ES17799673T Active ES2893456T3 (es) 2016-05-19 2017-05-18 Uso de un compuesto de carbamato para tratar preventivamente los dolores de cabeza

Country Status (8)

Country Link
US (2) US10456376B2 (enExample)
EP (1) EP3459541B1 (enExample)
JP (1) JP6986521B2 (enExample)
KR (1) KR102421006B1 (enExample)
CN (1) CN109310670B (enExample)
CA (1) CA3024278A1 (enExample)
ES (1) ES2893456T3 (enExample)
WO (1) WO2017200316A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2973111T3 (es) * 2017-11-14 2024-06-18 Sk Biopharmaceuticals Co Ltd Uso de un compuesto de carbamato para prevenir o tratar enfermedades asociadas con el aumento de la corriente tardía de sodio
CA3113052A1 (en) * 2018-09-21 2020-03-26 Sk Biopharmaceuticals Co., Ltd. Use of carbamate compound for prevention, alleviation, or treatment of status epilepticus
CA3112166A1 (en) * 2018-09-21 2020-03-26 Sk Biopharmaceuticals Co., Ltd. Carbamate compound and use of formulation comprising same in preventing, alleviating, or treating acute stress disorder or post-traumatic stress disorder
CA3157788A1 (en) * 2019-11-22 2021-05-27 Ji Hye Lee Oral pharmaceutical composition comprising carbamate compound and preparation method therefor

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3415840A (en) 1965-10-22 1968-12-10 American Home Prod Pyrazole-1-ethanol derivatives
DE2628420A1 (de) * 1976-06-24 1978-01-05 Bayer Ag 1-acyloxy-2-imidazolyl-1-phenyl- aethane, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide und nematizide
US4349556A (en) * 1976-06-24 1982-09-14 Bayer Aktiengesellschaft Pesticidally active 1-acyloxy-1-phenyl-2-azolyl-ethanes
EP1461309A1 (en) * 2001-12-21 2004-09-29 Ortho-McNeil Pharmaceutical, Inc. Process for preparing 2-(substituted phenyl) - 2 - hydroxy-ethyl carbamates
US20060194873A1 (en) * 2004-09-16 2006-08-31 Choi Yong M Methods of treating epileptogenesis and epilepsy
US7598279B2 (en) * 2005-04-22 2009-10-06 Sk Holdings Co., Ltd. Neurotherapeutic azole compounds
AU2009348523B2 (en) 2009-06-22 2015-02-26 Sk Biopharmaceuticals Co., Ltd. Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester
US8404461B2 (en) 2009-10-15 2013-03-26 SK Biopharmaceutical Co. Ltd. Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester
US9108368B2 (en) 2009-10-16 2015-08-18 Novartis Ag Apparatus and method for transporting contact lenses through dipping baths

Also Published As

Publication number Publication date
WO2017200316A1 (ko) 2017-11-23
JP2019516726A (ja) 2019-06-20
CN109310670A (zh) 2019-02-05
CN109310670B (zh) 2022-03-29
US10456376B2 (en) 2019-10-29
EP3459541A4 (en) 2020-01-08
KR102421006B1 (ko) 2022-07-14
US20200009113A1 (en) 2020-01-09
CA3024278A1 (en) 2017-11-23
EP3459541A1 (en) 2019-03-27
EP3459541B1 (en) 2021-09-15
US20190216780A1 (en) 2019-07-18
JP6986521B2 (ja) 2021-12-22
KR20170131240A (ko) 2017-11-29

Similar Documents

Publication Publication Date Title
ES2893456T3 (es) Uso de un compuesto de carbamato para tratar preventivamente los dolores de cabeza
ES2935596T3 (es) Compuesto de carbamato para prevenir o tratar la fibromialgia
ES2318113T3 (es) Combinaciones farmaceuticas de meloxicam,fosfato de codeina y paracetamol.
US11571410B2 (en) Use of carbamate compounds for prevention, alleviation or treatment of bipolar disorder
ES2887338T3 (es) Uso de un compuesto de carbamato para prevenir o tratar la neuralgia del trigémino
IL274431B1 (en) Use of a carbamate compound to reduce or treat developmental disorders including fragile X syndrome, Engelmann syndrome, or Rett syndrome
BR112012020169A2 (pt) utilização da agomelatina para a obtenção de medicamentos destinados ao tratamento do transtorno obsessivo compulsivo (toc).
JP2022503784A (ja) てんかん重積状態の予防、軽減又は治療のためのカルバメート化合物の使用
ES2978226T3 (es) Compuesto de carbamato y uso de la formulación que lo comprende para prevenir, aliviar o tratar el trastorno de estrés agudo o el trastorno de estrés postraumático
ES2975254T3 (es) Uso de compuestos de carbamato para la prevención, alivio o tratamiento del prurito
ES2973111T3 (es) Uso de un compuesto de carbamato para prevenir o tratar enfermedades asociadas con el aumento de la corriente tardía de sodio
HK40003858A (en) Use of carbamate compound in order to preventatively treat headaches
HK40003858B (en) Use of carbamate compound in order to preventatively treat headaches
RU2774970C2 (ru) Применение карбаматных соединений для профилактики, облегчения или лечения биполярного расстройства
HK40015213A (en) Use of carbamate compounds for prevention, alleviation or treatment of bipolar disorder
HK40005640B (en) Use of carbamate compound for preventing or treating fibromyalgia or functional syndrome associated with fibromyalgia
HK40005640A (en) Use of carbamate compound for preventing or treating fibromyalgia or functional syndrome associated with fibromyalgia